Loading…
Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β
The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid m...
Saved in:
Published in: | Signal transduction and targeted therapy 2023-11, Vol.8 (1), p.428-428, Article 428 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323 |
container_end_page | 428 |
container_issue | 1 |
container_start_page | 428 |
container_title | Signal transduction and targeted therapy |
container_volume | 8 |
creator | Yang, Hange Zhang, Xiaowei Wang, Cong Zhang, Hailong Yi, Juan Wang, Kun Hou, Yanzhe Ji, Peihong Jin, Xiaojie Li, Chenghao Zhang, Min Huang, Shan Jia, Haoyuan Hu, Kuan Mou, Lingyun Wang, Rui |
description | The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment. |
doi_str_mv | 10.1038/s41392-023-01667-2 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715</doaj_id><sourcerecordid>2889798188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</originalsourceid><addsrcrecordid>eNp9kU1uFDEUhFsIRKKQC7BAltiwSBP_je1eogiSkYLIIqyt1_abwaOe9mC7I-ZY5CA5E046BMSClS37cz1XVdO8ZvQ9o8KcZslEx1vKRUuZUrrlz5pDThddK5RYPP9rf9Ac57yhtGJC64V82RwI3SlhtD5s4HNwKbo4hJFcnBAgY7zBgcBU4u4brPckjH5ymE4I_sBUMtnFgmMhMJZQpm2cEgFXwk0oe9LvSYG0xhLGNblaXl_d_Ty9u33VvFjBkPH4cT1qvn76eH120V5-OV-efbhsnRSqtF51SqPzaDrQTIB30jnkAB0a9EBX0kvqqgNZLXfOCCcM47LnplPMCS6OmuWs6yNs7C6FLaS9jRDsw0FMawupBDeg7SU4jX3NRhoJxveOcumpZIwrr9miar2btXYpfp8wF7sN2eEwwIhxyrYOpUIxxXVF3_6DbmooY3VaKdPpzjBjKsVnqoadc8LV0wcZtfd92rlPW83Zhz7tvaM3j9JTv0X_9OR3exUQM5Dr1bjG9Gf2f2R_AUrIq1U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2889798188</pqid></control><display><type>article</type><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</creator><creatorcontrib>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</creatorcontrib><description>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</description><identifier>ISSN: 2059-3635</identifier><identifier>ISSN: 2095-9907</identifier><identifier>EISSN: 2059-3635</identifier><identifier>DOI: 10.1038/s41392-023-01667-2</identifier><identifier>PMID: 37963877</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/154/555 ; 631/92/556 ; 692/4028/67/1059/153 ; Animal models ; Animals ; Autophagy ; Autophagy - genetics ; Cancer Research ; Cancer therapies ; Cell Biology ; Cell death ; Cell Line, Tumor ; Internal Medicine ; Lipid metabolism ; Medicine ; Medicine & Public Health ; Mice ; Oncology ; Pathology ; Phosphatidylinositol ; Phosphatidylinositol transfer protein ; Phospholipid Transfer Proteins - chemistry ; Phospholipid Transfer Proteins - metabolism ; Proteomics ; Therapeutic targets ; Toxicity ; Tumor cell lines ; Tumors</subject><ispartof>Signal transduction and targeted therapy, 2023-11, Vol.8 (1), p.428-428, Article 428</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</cites><orcidid>0000-0002-0030-3234 ; 0000-0003-2448-2254</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2889798188/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2889798188?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37963877$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Hange</creatorcontrib><creatorcontrib>Zhang, Xiaowei</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Zhang, Hailong</creatorcontrib><creatorcontrib>Yi, Juan</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Hou, Yanzhe</creatorcontrib><creatorcontrib>Ji, Peihong</creatorcontrib><creatorcontrib>Jin, Xiaojie</creatorcontrib><creatorcontrib>Li, Chenghao</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Huang, Shan</creatorcontrib><creatorcontrib>Jia, Haoyuan</creatorcontrib><creatorcontrib>Hu, Kuan</creatorcontrib><creatorcontrib>Mou, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><title>Signal transduction and targeted therapy</title><addtitle>Sig Transduct Target Ther</addtitle><addtitle>Signal Transduct Target Ther</addtitle><description>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</description><subject>631/154/555</subject><subject>631/92/556</subject><subject>692/4028/67/1059/153</subject><subject>Animal models</subject><subject>Animals</subject><subject>Autophagy</subject><subject>Autophagy - genetics</subject><subject>Cancer Research</subject><subject>Cancer therapies</subject><subject>Cell Biology</subject><subject>Cell death</subject><subject>Cell Line, Tumor</subject><subject>Internal Medicine</subject><subject>Lipid metabolism</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mice</subject><subject>Oncology</subject><subject>Pathology</subject><subject>Phosphatidylinositol</subject><subject>Phosphatidylinositol transfer protein</subject><subject>Phospholipid Transfer Proteins - chemistry</subject><subject>Phospholipid Transfer Proteins - metabolism</subject><subject>Proteomics</subject><subject>Therapeutic targets</subject><subject>Toxicity</subject><subject>Tumor cell lines</subject><subject>Tumors</subject><issn>2059-3635</issn><issn>2095-9907</issn><issn>2059-3635</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1uFDEUhFsIRKKQC7BAltiwSBP_je1eogiSkYLIIqyt1_abwaOe9mC7I-ZY5CA5E046BMSClS37cz1XVdO8ZvQ9o8KcZslEx1vKRUuZUrrlz5pDThddK5RYPP9rf9Ac57yhtGJC64V82RwI3SlhtD5s4HNwKbo4hJFcnBAgY7zBgcBU4u4brPckjH5ymE4I_sBUMtnFgmMhMJZQpm2cEgFXwk0oe9LvSYG0xhLGNblaXl_d_Ty9u33VvFjBkPH4cT1qvn76eH120V5-OV-efbhsnRSqtF51SqPzaDrQTIB30jnkAB0a9EBX0kvqqgNZLXfOCCcM47LnplPMCS6OmuWs6yNs7C6FLaS9jRDsw0FMawupBDeg7SU4jX3NRhoJxveOcumpZIwrr9miar2btXYpfp8wF7sN2eEwwIhxyrYOpUIxxXVF3_6DbmooY3VaKdPpzjBjKsVnqoadc8LV0wcZtfd92rlPW83Zhz7tvaM3j9JTv0X_9OR3exUQM5Dr1bjG9Gf2f2R_AUrIq1U</recordid><startdate>20231115</startdate><enddate>20231115</enddate><creator>Yang, Hange</creator><creator>Zhang, Xiaowei</creator><creator>Wang, Cong</creator><creator>Zhang, Hailong</creator><creator>Yi, Juan</creator><creator>Wang, Kun</creator><creator>Hou, Yanzhe</creator><creator>Ji, Peihong</creator><creator>Jin, Xiaojie</creator><creator>Li, Chenghao</creator><creator>Zhang, Min</creator><creator>Huang, Shan</creator><creator>Jia, Haoyuan</creator><creator>Hu, Kuan</creator><creator>Mou, Lingyun</creator><creator>Wang, Rui</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0030-3234</orcidid><orcidid>https://orcid.org/0000-0003-2448-2254</orcidid></search><sort><creationdate>20231115</creationdate><title>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</title><author>Yang, Hange ; Zhang, Xiaowei ; Wang, Cong ; Zhang, Hailong ; Yi, Juan ; Wang, Kun ; Hou, Yanzhe ; Ji, Peihong ; Jin, Xiaojie ; Li, Chenghao ; Zhang, Min ; Huang, Shan ; Jia, Haoyuan ; Hu, Kuan ; Mou, Lingyun ; Wang, Rui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>631/154/555</topic><topic>631/92/556</topic><topic>692/4028/67/1059/153</topic><topic>Animal models</topic><topic>Animals</topic><topic>Autophagy</topic><topic>Autophagy - genetics</topic><topic>Cancer Research</topic><topic>Cancer therapies</topic><topic>Cell Biology</topic><topic>Cell death</topic><topic>Cell Line, Tumor</topic><topic>Internal Medicine</topic><topic>Lipid metabolism</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mice</topic><topic>Oncology</topic><topic>Pathology</topic><topic>Phosphatidylinositol</topic><topic>Phosphatidylinositol transfer protein</topic><topic>Phospholipid Transfer Proteins - chemistry</topic><topic>Phospholipid Transfer Proteins - metabolism</topic><topic>Proteomics</topic><topic>Therapeutic targets</topic><topic>Toxicity</topic><topic>Tumor cell lines</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Hange</creatorcontrib><creatorcontrib>Zhang, Xiaowei</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Zhang, Hailong</creatorcontrib><creatorcontrib>Yi, Juan</creatorcontrib><creatorcontrib>Wang, Kun</creatorcontrib><creatorcontrib>Hou, Yanzhe</creatorcontrib><creatorcontrib>Ji, Peihong</creatorcontrib><creatorcontrib>Jin, Xiaojie</creatorcontrib><creatorcontrib>Li, Chenghao</creatorcontrib><creatorcontrib>Zhang, Min</creatorcontrib><creatorcontrib>Huang, Shan</creatorcontrib><creatorcontrib>Jia, Haoyuan</creatorcontrib><creatorcontrib>Hu, Kuan</creatorcontrib><creatorcontrib>Mou, Lingyun</creatorcontrib><creatorcontrib>Wang, Rui</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Signal transduction and targeted therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Hange</au><au>Zhang, Xiaowei</au><au>Wang, Cong</au><au>Zhang, Hailong</au><au>Yi, Juan</au><au>Wang, Kun</au><au>Hou, Yanzhe</au><au>Ji, Peihong</au><au>Jin, Xiaojie</au><au>Li, Chenghao</au><au>Zhang, Min</au><au>Huang, Shan</au><au>Jia, Haoyuan</au><au>Hu, Kuan</au><au>Mou, Lingyun</au><au>Wang, Rui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β</atitle><jtitle>Signal transduction and targeted therapy</jtitle><stitle>Sig Transduct Target Ther</stitle><addtitle>Signal Transduct Target Ther</addtitle><date>2023-11-15</date><risdate>2023</risdate><volume>8</volume><issue>1</issue><spage>428</spage><epage>428</epage><pages>428-428</pages><artnum>428</artnum><issn>2059-3635</issn><issn>2095-9907</issn><eissn>2059-3635</eissn><abstract>The identification of effective drug targets and the development of bioactive molecules are areas of high need in cancer therapy. The phosphatidylinositol transfer protein alpha/beta isoform (PITPα/β) has been reported to play an essential role in integrating phosphoinositide trafficking and lipid metabolism in diverse cellular processes but remains unexplored as a potential target for cancer treatment. Herein, data analysis of clinical cancer samples revealed that PITPα/β expression is closely correlated with the poor prognosis. Target identification by chemical proteomic methods revealed that microcolin H, a naturally occurring marine lipopeptide, directly binds PITPα/β and displays antiproliferative activity on different types of tumour cell lines. Furthermore, we identified that microcolin H treatment increased the conversion of LC3I to LC3II, accompanied by a reduction of the level of p62 in cancer cells, leading to autophagic cell death. Moreover, microcolin H showed preeminent antitumour efficacy in nude mouse subcutaneous tumour models with low toxicity. Our discoveries revealed that by targeting PITPα/β, microcolin H induced autophagic cell death in tumours with efficient anti-proliferating activity, which sheds light on PITPα/β as a promising therapeutic target for cancer treatment.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>37963877</pmid><doi>10.1038/s41392-023-01667-2</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0030-3234</orcidid><orcidid>https://orcid.org/0000-0003-2448-2254</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2059-3635 |
ispartof | Signal transduction and targeted therapy, 2023-11, Vol.8 (1), p.428-428, Article 428 |
issn | 2059-3635 2095-9907 2059-3635 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_b4ac7eb635484a8dbc024d041126d715 |
source | Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 631/154/555 631/92/556 692/4028/67/1059/153 Animal models Animals Autophagy Autophagy - genetics Cancer Research Cancer therapies Cell Biology Cell death Cell Line, Tumor Internal Medicine Lipid metabolism Medicine Medicine & Public Health Mice Oncology Pathology Phosphatidylinositol Phosphatidylinositol transfer protein Phospholipid Transfer Proteins - chemistry Phospholipid Transfer Proteins - metabolism Proteomics Therapeutic targets Toxicity Tumor cell lines Tumors |
title | Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A05%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microcolin%20H,%20a%20novel%20autophagy%20inducer,%20exerts%20potent%20antitumour%20activity%20by%20targeting%20PITP%CE%B1/%CE%B2&rft.jtitle=Signal%20transduction%20and%20targeted%20therapy&rft.au=Yang,%20Hange&rft.date=2023-11-15&rft.volume=8&rft.issue=1&rft.spage=428&rft.epage=428&rft.pages=428-428&rft.artnum=428&rft.issn=2059-3635&rft.eissn=2059-3635&rft_id=info:doi/10.1038/s41392-023-01667-2&rft_dat=%3Cproquest_doaj_%3E2889798188%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c436t-d6967ecde89a713adc4cce2aa9e8eda0f4d40c63740239c83c38124b28961c323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2889798188&rft_id=info:pmid/37963877&rfr_iscdi=true |